Shipped from our Warehouse in Pennsylvania

Kijimea PRO – for your gut barrier

  • Supports intestinal integrity and gut barrier function*
  • Helps to reduce occasional bloating, constipation and diarrhea*
  • May help to support gastrointestinal comfort*
  • Specialized high adhesion probiotics with patented B. Bifidum MIMBb75
SHOP NOW

30-day money-back guarantee. Free shipping on subscriptions.

As featured in

How might you benefit from Kijimea PRO?

1-2months
  • Some symptoms may already improve, i.e. reduced episodes of occasional diarrhea*
  • First changes in your gut barrier can be detected – i.e. intestinal barrier integrity*
3-6months
  • Experience more regular bowel habits*
  • Feel less occasional bloating and constipation*
6+months
  • Experience increased gastrointestinal comfort*
  • Feel good about your gut*

*Note: Individual results may vary. The benefits stated are based on personal experiences and subjective feedback from users of Kijimea K53 products and may vary from person to person.

Join all of our monthly Kijimea PRO probiotics subscribers

You'll save money, time, and effort. It takes consistency and commitment to truly see the biggest results. By joining our subscription program, you'll get access to:

  • Probiotic blend for gastrointestinal health
  • Personal KIJIMEA customer service assistant
  • Plus so much more!

Order now, pay later with:

Apple Pay, Google Pay, PayPal

This is what happy Kijimea PRO product testers have to say

Anna

Anna

Anna

100% Refund Policy

We offer a 100% money-back guarantee within 30 days of receiving any product. Try it out, if you're not happy we'll refund your purchase.

GUARANTEED SAFE CHECKOUT

  • Scientifically validated probiotic strains

    Specialized high adhesion probiotic, featuring shelf-stable probiotic strains for targeted support including patented B. bifidum MIMBb75, L. rhamnosus GG, L. rhamnosus IMC 501, L. paracasei IMC 502. Backed by gold standard clinical studies.

Our benefits

A carefully sourced, scientifically crafted formula for your gastrointestinal health*

Targeted approach for your gut barrier function

Kijimea PRO is specifically formulated to support the gut barrier function and reduce occasional bloating, diarrhea and constipation*. It combines 4 clinically validated strains, incl. patented B. bifidum MIMBb75.

Gastrointestinal Health

Recent research suggests that specific probiotic strains can support your gastrointestinal comfort: Kijimea PRO contains the #1 Doctor recommended B. bifidum from Europe and the world’s most clinically studied strain L. rhamnosus GG.  

Leading probiotic from Germany

In Europe, Kijimea PRO is already among the
most-sold, scientifically researched probiotics – with more than 3.4 million happy customers.

Each serving of Kijimea PRO contains

  • Patented B. bifidum MIMBb75

    Supports your gastrointestinal comfort*

  • World’s most studied strain L. rhamnosus GG

    For your gut barrier function*

  • Intestinal regularity blend

    Powerful combination of L. rhamnosus IMC 501 and L. paracasei IMC 502 

    Reduces occasional constipation and bloating*

Kijimea PRO – The Best Probiotic Supplement on the Market

Kijimea product packshot
Others

Patented strain B. bifidum MIMBb75

Specialized high adhesion bacteria

rare

Moisture-proof alu-alu single packaging of each capsule

rarely blister packs

Manufacturer's own clinical studies

rare
SHOP NOW

30-day money-back guarantee. Free shipping on subscriptions.

Our ingredients

4

Strains.

Patented

B. bifidum MIMBb75

Kijimea PRO is specifically formulated to support gut barrier function and gastrointestinal comfort*, helping to reduce occasional bloating, diarrhea and constipation. It combines four clinically validated strains, including the patented B. bifidum MIMBb75 and L. rhamnosus GG, the world’s most extensively studied probiotic bacterial strain.

Clinically validated to support intestinal integrity and gut barrier function.*
Reinforces healthy tight junctions (in-vitro)*

Key strain:

  • L. rhamnosus GG

Reduces occasional constipation and bloating, supports intestinal regularity*

Key strains:

  • L. rhamnosus IMC 501 (0.5 x 10⁹ CFU)
  • L. paracasei IMC 502 (0.5 x 10⁹ CFU)

Patented Bifidobacterium bifidum MIMBb75 may support gastrointestinal comfort and help to reduce occasional bloating*

Key strain:

  • B. bifidum MIMBb75
Supplement Facts
Our ingredients
Our ingredients

This is what happy Kijimea PRO product testers have to say

  • Julie-Ann Skinner

    Verified Buyer

    Feel so much better

    "Feel so much better taking these my digestion feels a lot better and I feel overall healthier."

  • Sarah Boyce

    Verified Buyer

    Effective...

    "Since taking this my symptoms have pretty much disappeared which is amazing considering how long I've been suffering!

    I highly recommend this product."

  • Claire Hill

    Verified Buyer

    I am very satisfied with the product.

    "I have only been taking these for nearly two weeks but do feel they are making a difference and my symptoms of IBS seem to be improving. I have recommended them also to a few friends who have the same problem. "

  • Erika Hopkins

    Verified Buyer

    Very positive experience overall.

    "So far this has been the best product I have tried. I am Not diagnosed with IBS but I have always been plagued with similar symptoms especially bloating difficulties and this has been the only product that has helped, the bloating has subsided."

SHOP NOW

30-day money-back guarantee. Free shipping on subscriptions.

  • Our mission

    Make probiotics the foundation of a longer and healthier life – for all.

  • 100% Satisfaction on all our products

    We want you to be 100% satisfied with your Kijimea products. That's why every order comes with a 30-day money-back guarantee.

Questions? We are happy to help

What can I expect while taking Kijimea PRO?

Kijimea PRO is a probiotic supplement specifically formulated to support the gut barrier function and gastrointestinal comfort*. It combines 4 clinically validated strains, incl. patented B. bifidum MIMBb75.

How do I take Kijimea PRO?

Take one capsule daily with sufficient amount of water. Daily use for at least 12 weeks is recommended.

Do not exceed recommended daily dose. Keep out of reach of children.

Why should I take Kijimea PRO daily?

Consistent use can help to support the benefits of the clinically studied strains*.
We recommend a daily use for at least 12 weeks. When starting, the gut microbiome may take some time to adjust to the daily introduction of probiotics.

Do I need to refrigerate Kijimea PRO?

No refrigeration is necessary.

Is Kijimea PRO safe to take while I'm pregnant or breastfeeding?

As with any dietary supplement or new health protocol, we recommend consulting a healthcare professional before you start consuming Kijimea PRO if you are pregnant or breastfeeding or trying to become pregnant.

What pack sizes of Kijimea PRO are available?

Kijimea PRO is available in the following pack size: 30 capsules of 0.28 g each = 8.4 g.

Is Kijimea PRO suitable for children?

Kijimea PRO is suitable for adults and children over the age of 12.
As with any dietary supplement or new health protocol we recommend consulting a healthcare professional before you start consuming Kijimea PRO.

Is Kijimea PRO well tolerated?

There are no known side effects and interactions associated with the consumption of Kijimea PRO. Consult your healthcare professional if you are taking, have recently taken or are planning to take any medicines together with Kijimea PRO.

This product contains no allergens according to Food Allergen Labeling and Consumer Protection Act (FALCPA).

Who is the distributor of Kijimea PRO?

The product is distributed by Kijimea Inc. (120 Wall Street, New York, NY 10005)

SHOP NOW

30-day money-back guarantee. Free shipping on subscriptions.

References

Agamennone V, Krul CAM, Rijkers G, Kort R. A practical guide for probiotics applied to the
case of antibiotic-associated diarrhea in The Netherlands. BMC Gastroenterol. 2018 Aug 6;18(1):103. doi: 10.1186/s12876-018-0831-x. PMID: 30078376; PMCID: PMC6091175.

Chen L, Li H, Li J, Chen Y, Yang Y. Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates microbiota dysbiosis in an experimental model of sepsis. Int J Mol Med. 2019 Mar;43(3):1139-1148. doi:
10.3892/ijmm.2019.4050. Epub 2019 Jan 7. PMID: 30628657; PMCID: PMC6365041.

Dronkers TMG, Ouwehand AC, Rijkers GT. Global analysis of clinical trials with probiotics. Heliyon. 2020 Jul 17;6(7):e04467. doi: 10.1016/j.heliyon.2020.e04467. PMID: 32715136; PMCID: PMC7371762.

Francavilla R, Miniello V, Magistà AM, De Canio A, Bucci N, Gagliardi F, Lionetti E, Castellaneta S, Polimeno L, Peccarisi L, Indrio F, Cavallo L. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics. 2010 Dec;126(6):e1445-52. doi: 10.1542/peds.2010-0467. Epub 2010 Nov 15. PMID: 21078735.

Ge Y, Sun H, Xu L, Zhang W, Lv J, Chen Y. The amelioration of alcohol-induced liver and intestinal barrier injury by Lactobacillus rhamnosus Gorbach-Goldin (LGG) is dependent on Interleukin 22 (IL-22) expression. Bioengineered. 2022
May;13(5):12650-12660. doi: 10.1080/21655979.2022.2070998. PMID: 35603884; PMCID: PMC9275995.

Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study. Aliment Pharmacol
Ther. 2011 May;33(10):1123-32. doi: 10.1111/j.1365-2036.2011.04633.x. Epub 2011 Mar 21. PMID: 21418261.

Guglielmetti S, Tamagnini I, Mora D, Minuzzo M, Scarafoni A, Arioli S, Hellman J, Karp M,
Parini C. Implication of an outer surface lipoprotein in adhesion of Bifidobacterium bifidum to Caco-2 cells. Appl Environ
Microbiol. 2008 Aug;74(15):4695-702. doi: 10.1128/AEM.00124-08. Epub 2008 Jun
6. PMID: 18539800; PMCID: PMC2519326.

Han X, Lee A, Huang S, Gao J, Spence JR, Owyang C. Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids. Gut Microbes. 2019;10(1):59-76. doi: 10.1080/19490976.2018.1479625. Epub 2018 Aug 6. PMID: 30040527; PMCID:
PMC6363076.

Huang FC, Huang SC. The Hazards of Probiotics on Gut-Derived Pseudomonas aeruginosa Sepsis in Mice Undergoing Chemotherapy. Biomedicines. 2024 Jan 23;12(2):253. doi: 10.3390/biomedicines12020253. PMID: 38397855;
PMCID: PMC10886725.

Li N, Russell WM, Douglas-escobar M, Hauser N, Lopez M, Neu J. Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats. Pediatr Res. 2009 Aug;66(2):203-7. doi: 10.1203/PDR.0b013e3181aabd4f. PMID: 19390478.

Li X, Hu B, Zheng J, Pan Z, Cai Y, Zhao M, Jin X, Li ZQ. Probiotics Alleviate Chemotherapy-Associated Intestinal Mucosal Injury via the TLR4-NFκB Signaling Pathway. Drug Des Devel Ther. 2023 Jul 25;17:2183-2192. doi: 10.2147/DDDT.S403087. PMID: 37521036; PMCID: PMC10386857.

Li X, Zheng P, Cao W, Cao Y, She X, Yang H, Ma K, Wu F, Gao X, Fu Y, Yin J, Wei F, Jiang S, Cui B. Lactobacillus rhamnosus GG ameliorates noise-induced cognitive deficits and systemic inflammation in rats by modulating the gut-brain axis. Front Cell Infect Microbiol. 2023 Apr 26;13:1067367. doi: 10.3389/fcimb.2023.1067367. PMID: 37180445; PMCID: PMC10169735.

Li YT, Xu H, Ye JZ, Wu WR, Shi D, Fang DQ, Liu Y, Li LJ. Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: A systematic review with meta-analysis. World J Gastroenterol. 2019 Sep 7;25(33):4999-5016. doi: 10.3748/wjg.v25.i33.4999. PMID: 31543689; PMCID: PMC6737314.

Liu F, Li G, Wen K, Wu S, Zhang Y, Bui T, Yang X, Kocher J, Sun J, Jortner B, Yuan L. Lactobacillus rhamnosus GG on rotavirus-induced injury of ileal epithelium in gnotobiotic pigs. J Pediatr Gastroenterol Nutr. 2013 Dec;57(6):750-8. doi: 10.1097/MPG.0b013e3182a356e1. PMID: 24280990; PMCID: PMC3843150.

Mao J, Qi S, Cui Y, Dou X, Luo XM, Liu J, Zhu T, Ma Y, Wang H. Lactobacillus rhamnosus GG Attenuates Lipopolysaccharide-Induced Inflammation and Barrier Dysfunction by Regulating MAPK/NF-κB Signaling and Modulating Metabolome in the Piglet Intestine. J Nutr. 2020 May 1;150(5):1313-1323. doi: 10.1093/jn/nxaa009. PMID: 32027752.

Mao X, Gu C, Hu H, Tang J, Chen D, Yu B, He J, Yu J, Luo J, Tian G. Dietary Lactobacillus rhamnosus GG Supplementation Improves the Mucosal Barrier Function in the Intestine of Weaned Piglets Challenged by Porcine Rotavirus. PLoS One. 2016 Jan 4;11(1):e0146312. doi: 10.1371/journal.pone.0146312. PMID: 26727003; PMCID: PMC4699646.

McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006 Apr;101(4):812-22. doi: 10.1111/j.1572-0241.2006.00465.x.
PMID: 16635227.

Orlando A, Linsalata M, Bianco G, Notarnicola M, D'Attoma B, Scavo MP, Tafaro A, Russo F. Lactobacillus rhamnosus GG Protects the Epithelial Barrier of Wistar Rats from the Pepsin-Trypsin-Digested Gliadin (PTG)-Induced Enteropathy. Nutrients. 2018
Nov 7;10(11):1698. doi: 10.3390/nu10111698. PMID: 30405050; PMCID: PMC6265991.

Panpetch W, Visitchanakun P, Saisorn W, Sawatpanich A, Chatthanathon P, Somboonna N, Tumwasorn S, Leelahavanichkul A. Lactobacillus rhamnosus attenuates Thai chili extracts induced gut inflammation and dysbiosis despite capsaicin bactericidal effect against the probiotics, a possible toxicity of high dose capsaicin. PLoS One. 2021 Dec 23;16(12):e0261189. doi: 10.1371/journal.pone.0261189. PMID: 34941893; PMCID:
PMC8699716.

Patel RM, Myers LS, Kurundkar AR, Maheshwari A, Nusrat A, Lin PW. Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am J Pathol. 2012 Feb;180(2):626-35. doi: 10.1016/j.ajpath.2011.10.025. Epub 2011
Dec 5. Erratum in: Am J Pathol. 2012 Mar;180(3):1324. doi: 10.1016/j.ajpath.2011.12.010. PMID: 22155109; PMCID: PMC3349863.

Ritze Y, Bárdos G, Claus A, Ehrmann V, Bergheim I, Schwiertz A, Bischoff SC. Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PLoS One. 2014 Jan 27;9(1):e80169. doi: 10.1371/journal.pone.0080169. PMID:
24475018; PMCID: PMC3903470.

Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis. 2006 Jun;6(6):374-82. doi: 10.1016/S1473-3099(06)70495-9. PMID: 16728323.

Sentongo TA, Cohran V, Korff S, Sullivan C, Iyer K, Zheng X. Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome. J Pediatr Gastroenterol Nutr. 2008 Jan;46(1):41-7. doi: 10.1097/01.mpg.0000304452.92175.f5. PMID: 18162832.

Silvi S, Verdenelli MC, Cecchini C, Coman MM, Bernabei MS, Rosati J, De Leone R, Orpianesi C, Cresci A. Probiotic-enriched foods and dietary supplement containing SYNBIO positively affects bowel habits in healthy adults: an assessment using standard statistical analysis and Support Vector Machines. Int J Food Sci Nutr. 2014 Dec;65(8):994-1002. doi: 10.3109/09637486.2014.940284.
Epub 2014 Jul 21. PMID: 25045832.

Sultana R, McBain AJ, O'Neill CA. Strain-dependent augmentation of tight-junction barrier function in human primary epidermal keratinocytes by Lactobacillus and Bifidobacterium lysates. Appl Environ Microbiol. 2013 Aug;79(16):4887-94. doi:
10.1128/AEM.00982-13. Epub 2013 Jun 14. PMID: 23770906; PMCID: PMC3754719.

Szajewska H, Konarska Z, Kołodziej M. Probiotic Bacterial and Fungal Strains: Claims with Evidence. Dig Dis. 2016;34(3):251-9. doi: 10.1159/000443359. Epub 2016 Mar 30. PMID: 27028756.

SzajewskanH, Kołodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther. 2015 Nov;42(10):1149-57. doi: 10.1111/apt.13404.
Epub 2015 Sep 13. PMID: 26365389.

Szajewska H, Skórka A, Ruszczyński M, Gieruszczak-Białek D. Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther. 2007 Apr 15;25(8):871-81. doi: 10.1111/j.1365-2036.2007.03282.x. PMID: 17402990.

Vandenplas Y, Huys G, Daube G. Probiotics: an update. J Pediatr (Rio J). 2015 Jan-Feb;91(1):6-21. doi: 10.1016/ j.jped.2014.08.005. Epub 2014 Oct 23. PMID: 25458874.

Zhao H, Zhao C, Dong Y, Zhang M, Wang Y, Li F, Li X, McClain C, Yang S, Feng W. Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occludin expression and protects mice from alcoholic liver disease. Toxicol Lett. 2015 May 5;234(3):194-200. doi: 10.1016/j.toxlet.2015.03.002. Epub 2015 Mar 5. PMID: 25746479.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

The reviews and user experiences presented on this website are based on voluntary feedback from real customers. They reflect individual experiences and may not be representative of typical results.